Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation Group.

Salivary binding antibodies induced by candidate human immunodeficiency virus type 1 (HIV-1) vaccines in healthy, HIV-1 uninfected volunteers were assessed in a clinical trial evaluating intramuscularly injected HIV-1MN recombinant gp120 (rgp120) vaccine alone or with HIV-1IIIB rgp120 vaccine. The t...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Clin Diagn Lab Immunol
Päätekijät:	Gorse, G J, Yang, E Y, Belshe, R B, Berman, P W
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1996
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC170445/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8914773/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.3.6.769-773.1996
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!